Skip to main content

Gender-affirming care · UK

Masculinizing hormone therapy, without the five-year wait.

Testosterone GAHT in the UK - WPATH SoC 8 aligned, informed-consent, specialist-led. NHS Gender Identity Clinic route where it fits; private specialist care where it does not. Fertility counselling first, monitoring for life.

See indicative pricing
A radiographer guides a patient onto the bed of an advanced 3 Tesla MRI scanner in a London imaging suite

Indicative pricing

What masculinizing hormone therapy costs in the UK.

NHS via a Gender Identity Clinic is free at the point of use - but the wait is measured in years. Private specialist ranges below.

In short

Private initial: £150–£350, then £30–£80/month prescription plus monitoring.

Item Indicative range
Initial specialist consultation £150–£350
Baseline hormone + safety bloods £180–£320
Testosterone prescription (monthly) £30–£80
Sustanon 250mg IM (per ampoule) £8–£15
Nebido 1000mg (long-acting depot) £85–£120
Monitoring bloods (per round) £120–£220
Follow-up review consultation £120–£250
NHS Gender Identity Clinic pathway Free (NHS)

Prices vary by clinician, by which regimen you choose, and by how often you need bloods in the first year.

The problem

The right clinician, the right regimen, the right monitoring.

UK gender care is a two-track system - NHS with a multi-year wait, and a fragmented private market. Which track fits depends on your circumstances, and care continues afterwards either way.

  • Waiting years for an NHS GIC?

    A private bridging assessment and prescription is a valid, safe route while you wait - with proper monitoring and GP shared-care support.

  • Not sure which regimen fits?

    Sustanon, Nebido, subcutaneous T, gel - each has trade-offs.

  • Fertility still on the table?

    Egg or embryo freezing is time-sensitive. It is best raised at the first conversation, not after you have started.

When it helps

Who masculinizing hormone therapy is for.

The situations that come up most, plus the red flag on testosterone that means an emergency rather than a routine call.

  • Trans-masculine adults

    Adults seeking physical masculinization aligned with gender identity - informed-consent model where appropriate, WPATH SoC 8 aligned.

  • Non-binary people wanting T effects

    Some non-binary people want partial or full testosterone effects - dose and duration can be tailored to the outcome you want.

  • Intersex adults on GAHT

    Intersex adults choosing masculinizing hormones as part of their own care plan - coordinated with any existing endocrinology.

  • On the NHS GIC waiting list

    Waits of 5–7+ years for a first NHS GIC appointment are well documented. Private bridging assessment and prescribing is a valid option.

  • Established on T, need continuity

    You are stable on testosterone but your prescribing route has failed - private continuity, monitoring, and GP shared-care support.

  • Considering restarting T

    You paused hormones - for fertility, health, or life reasons - and want a considered restart with proper baseline work.

  • Wanting fertility preservation first

    Egg or embryo freezing before starting testosterone is time-sensitive, so it is best raised at the first consultation, not months in.

  • Red flag: chest pain, sudden swelling

    New chest pain, unilateral leg swelling, sudden shortness of breath or severe headache on testosterone is an emergency - 999 or A&E, not a clinic call.

Regimen options

More than one way to deliver testosterone.

What each regimen on the table actually involves - and which fits which lifestyle and body.

  • Sustanon 250mg IM

    Intramuscular testosterone, 2–3 weekly. The most familiar UK regimen - reliable, well-monitored, deep gluteal or thigh injection.

  • Nebido 1000mg IM (depot)

    Long-acting testosterone undecanoate, 10–14 weekly. Very steady levels, fewer injections - needs slow deep IM administration by a clinician.

  • Subcutaneous testosterone

    50–100mg weekly, self-administered subcutaneously. Many patients prefer it - steadier levels, small needle, no clinic visit for every dose.

  • Transdermal gel (Tostran, Testogel, Testavan)

    Applied daily to shoulders, upper arms or abdomen. Steady levels, no needles - but skin-transfer risk means careful application and covering.

  • Combined with GnRH analogue

    Zoladex or Prostap alongside testosterone can suppress endogenous ovulation for those who want it - a specialist decision, not routine.

  • Bridging prescription

    A private prescription that keeps you safe on hormones while you wait for an NHS GIC - with proper monitoring and a GP shared-care plan.

  • Continuity of care

    If you are already established on T, prescribing, monitoring and titration need a reliable route when your current one stops working.

  • Assessment only

    An honest conversation about whether hormones are right for you now, what to prepare, and which pathway fits - no pressure to start.

Safety and monitoring

What to expect on testosterone - honestly.

Masculinizing hormone therapy is well established and safe when monitored properly. The things worth planning are your regimen, your monitoring cadence, and the red flags that mean stop and call.

  • Polycythaemia is the commonest issue

    Testosterone raises haematocrit. If it climbs above 0.52 the usual response is to cut the dose, switch delivery, or arrange venesection. It is why bloods matter.

  • Lipid changes are expected

    LDL tends to rise, HDL to fall. They are tracked, and treated if they matter clinically - usually lifestyle first.

  • Acne and oily skin, especially early

    Weeks one to six are often the worst. Topical treatment, sometimes oral, usually handles it. It settles as levels stabilise.

  • Voice deepening is usually permanent

    Most voice change happens in the first 6–12 months, and is usually irreversible. Speech and language therapy can support the transition.

  • Fertility drops - but is not always gone

    Testosterone reduces fertility, sometimes reversibly. Pregnancy is possible on T if pelvic organs are retained - contraception still applies.

  • Sleep apnoea risk rises

    Weight gain, muscle mass and hormonal shifts can trigger or worsen obstructive sleep apnoea. Snoring or daytime sleepiness warrants a review.

  • Mood changes settle

    Early weeks can bring irritability or emotional flatness. Most people feel more settled once levels stabilise - worth flagging, not ignoring.

  • Cardiovascular monitoring is lifelong

    Long-term cardiovascular evidence is still maturing, so BP, lipids, glucose and weight are monitored annually, long term.

  • Red flags

    New chest pain, one-sided leg swelling, sudden severe headache, breathlessness or visual changes are emergencies - 999 or A&E, same day.

Reading your care plan

Your care plan in four parts. Read the last one first.

Whichever regimen you start on, the letter your specialist sends keeps to the same shape.

A UK endocrinologist reviewing a patient’s hormone care plan

A quiet reminder

Endocrine language is precise and can read coldly - it helps to have it explained plainly.

If anything in the plan is unclear, ask your prescriber to talk you through it before your first review.

  1. 01 Header

    Diagnosis, regimen and starting dose

    What was prescribed - Sustanon, Nebido, subcutaneous T, gel - the dose, the frequency, and why this regimen was chosen for you.

  2. 02 Baseline

    Baseline bloods and physiology

    Your pre-treatment testosterone, oestradiol, LH, FSH, FBC, LFTs, lipids, HbA1c, U+Es, BP and weight. The numbers dosing is titrated against.

  3. 03 Findings

    Effects timeline and monitoring plan

    What to expect week by week, month by month; when to have your next bloods; the target testosterone range (10–30 nmol/L).

  4. 04 Impression

    Fertility, contraception and follow-up

    Read this first: fertility preservation options if not yet done, contraception if pelvic organs are retained, next review date, and safety-net advice.

Recognised by major UK insurers

BupaAXA HealthVitalityAvivaWPACignaHealixBupaAXA HealthVitalityAvivaWPACignaHealixBupaAXA HealthVitalityAvivaWPACignaHealix

Insurance cover for gender-affirming hormone therapy varies significantly by insurer and by policy - often excluded or partially covered.

Frequently asked

Common questions about masculinizing hormone therapy.

Quick answers on pathways, regimens, timeline, fertility, cost, and monitoring.

  • Who can start masculinizing hormone therapy in the UK?

    Adults over 18 through the NHS routinely, and adults privately under a WPATH SoC 8 aligned informed-consent model. Adolescent pathways exist privately with specialist multidisciplinary support, and are handled cautiously post-Cass Review.

  • NHS or private - which pathway should I choose?

    Both are valid. NHS via a Gender Identity Clinic is free but the wait for a first appointment is well-documented at 5–7 years or more. Private specialist care is weeks to months, costs £150–£350 initial plus monthly prescription and monitoring, and can bridge you while you wait for the NHS.

  • What are the delivery options for testosterone?

    Sustanon 250mg intramuscular every 2–3 weeks; Nebido 1000mg intramuscular depot every 10–14 weeks; subcutaneous testosterone 50–100mg weekly (many prefer this for steadier levels); or a daily transdermal gel like Tostran, Testogel or Testavan. Choice depends on preference, lifestyle, and clinical fit.

  • What effects can I expect, and when?

    Weeks 1–6: increased libido, oily skin, acne, mood shifts. Months 1–6: voice deepening (usually permanent), facial and body hair, fat redistribution, muscle mass with resistance training, cessation of menses (typically 2–6 months), clitoromegaly. Months 6–24: continued voice and hair changes, possible scalp hair recession.

  • What does testosterone not change?

    Adult skeletal structure does not change. Breast tissue does not reduce - that needs top surgery (see masculinizing surgery). Reproductive organs remain unless removed surgically. Facial hair is often incomplete if you start over 30–40.

  • How is monitoring done?

    Bloods every three months for the first year, then every six months lifelong - testosterone level (trough for depot, mid-cycle for injections), FBC for polycythaemia, LFTs, lipids, HbA1c, plus weight and BP at every review. Target testosterone is 10–30 nmol/L, the physiological adult male range.

  • What about fertility?

    Testosterone reduces fertility, sometimes but not always reversibly. Egg or embryo freezing before starting hormones is the safest way to preserve options - it is time-sensitive and should be raised at the first consultation. Pregnancy is possible on testosterone if pelvic organs are retained, so contraception is still needed if that applies to you.

  • What does private masculinizing hormone therapy cost in the UK?

    Initial specialist consultation £150–£350; baseline bloods £180–£320; monthly testosterone prescription £30–£80; monitoring bloods £120–£220 per round; follow-up reviews £120–£250. NHS via a GIC is free at point of use but the waiting list is long.

  • What are the risks I should know about?

    Polycythaemia (raised haematocrit - sometimes needing venesection or dose reduction), lipid shifts (LDL up, HDL down), acne, sleep apnoea risk, androgenetic alopecia in those predisposed, mood changes early on, permanent voice change, reduced fertility, and evolving long-term cardiovascular and prostate risk data. Lifelong monitoring is the safety net.

  • When should I see A&E or call 999?

    New chest pain, one-sided leg swelling or pain, sudden shortness of breath, severe headache, sudden visual change or signs of stroke on testosterone are emergencies - call 999 or go to A&E, do not wait for a clinic appointment.

Related treatments

Looking for something else?